Naloxone Spray Market Report 2026

Naloxone Spray Market Overview

• Naloxone Spray market size has reached to $810.65 billion in 2025 • Expected to grow to $2428.63 billion in 2030 at a compound annual growth rate (CAGR) of 24.6% • Growth Driver: Telemedicine Revolutionizes Naloxone Spray Market By Addressing The Opioid Crisis Remotely • Market Trend: Product Approvals Driving Expansion In The Naloxone Spray Market • North America was the largest region in 2025.

What Is Covered Under Naloxone Spray Market?

Naloxone spray refers to a substance that binds to opioid receptors and inhibits or reverses the actions of other opioids. Giving naloxone quickly undoes the effects of opioid medications, returning breathing to normal. It may be given intravenously or through nasal spray. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once. The main types of dosages involved in the naloxone spray include 2 mg/actuation and 4 mg actuation. 2 mg/actuation sprays naloxone is equivalent to 1.8 mg naloxone and is used for emergency medication of known or suspected opioid overdose, as demonstrated by respiratory and/or central nervous system depression. The 2mg dose is licensed for use in opioid-dependent individuals who are at risk of severe opioid withdrawal and who live in an environment with a low risk of accidental or purposeful opioid exposure by household contacts. Naloxone sprays are available in various distribution channels such as hospitals, clinics, retail pharmacies, online pharmacies, others.

What Is The Naloxone Spray Market Growth Forecast?

The naloxone spray market size is expected to see exponential growth in the next few years. It will grow to $2428.63 billion in 2030 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to rising awareness of naloxone nasal sprays, growth in OTC naloxone products, technological advancements in spray delivery systems, expansion of emergency response networks, favorable reimbursement policies. Major trends in the forecast period include rapid adoption of intranasal administration, expansion of over-the-counter availability, rising opioid overdose cases driving demand, development of patient-friendly single-dose formats, integration with emergency response protocols.

Global Naloxone Spray Market Segmentation

1) By Product Type: Prescription Naloxone Spray, Over-The-Counter (OTC) Naloxone Spray 2) By Dosage: 2 mg Or Actuation, 4 mg Or Actuation 3) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other distribution channels

What Is The Driver Of The Naloxone Spray Market?

The increasing demand for telemedicine is expected to propel the growth of the naloxone spray market going forward. Telemedicine, also known as telehealth, is a healthcare delivery method that involves the use of technology and telecommunications to provide medical services and consultations remotely. Telemedicine offers more comprehensive, accessible, and immediate support to individuals at risk of opioid overdose, potentially saving lives and addressing the opioid crisis more effectively. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, national telehealth use increased by 7.3%, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing demand for telemedicine is driving the growth of the naloxone spray industry.

Key Players In The Global Naloxone Spray Market

Major companies operating in the naloxone spray market are Emergent BioSolutions Inc., Amphastar Pharmaceuticals Inc., Hikma Pharmaceuticals plc, Indivior plc, Nasus Pharma LLC, Opiant Pharmaceuticals Inc., Pfizer Inc., Samarth Pharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Adapt Pharma Inc., Cardinal Health Inc., Kaleo Inc., McKesson Corporation, Mundipharma International Limited, NextDistro Inc., Rite Aid Corporation, Novartis International AG, Sandoz International GmbH, Fresenius Kabi USA LLC, West-Ward Pharmaceuticals Corp., Lupin Ltd.

Global Naloxone Spray Market Trends and Insights

Major companies operating in the naloxone spray market are focusing on developing innovative solutions, such as over-the-counter (OTC) naloxone hydrochloride (HCl) nasal sprays, to meet the rising demand for wider community access, rapid overdose reversal, and simplified administration. Naloxone nasal spray is a needle-free formulation designed for quick intranasal delivery, offering easier use and faster deployment compared with traditional injectable naloxone that requires trained healthcare professionals. For instance, in May 2024, Walgreens, a US-based company, announced the launch of Walgreens Brand Naloxone HCl Nasal Spray. This over-the-counter product is designed to rapidly reverse the effects of opioid overdose, providing a crucial tool in combating the opioid epidemic. Naloxone works by blocking the effects of opioids on the brain, restoring normal breathing and preventing death when administered in time. Despite its proven efficacy, access to naloxone remains limited in many communities, highlighting the importance of this launch in increasing availability and awareness.

What Are Latest Mergers And Acquisitions In The Naloxone Spray Market?

In June 2025, Navamedic ASA, a Norway-based provider of specialty pharmaceuticals, acquired DNE Pharma AS for up to USD 22 million. Through this acquisition, Navamedic aims to strengthen its presence in the naloxone spray market and broaden its addiction-treatment portfolio by integrating DNE Pharma’s intranasal naloxone product Ventizolve and related opioid-dependence treatments. DNE Pharma AS is a Norway-based pharmaceutical company that provides addiction-treatment products, including the Ventizolve naloxone nasal spray used for emergency opioid overdose reversal.

Regional Insights

North America was the largest region in the naloxone spray market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Naloxone Spray Market?

The naloxone spray market consists of sales of injectable and prepackaged nasal spray. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Naloxone Spray Market Report 2026?

The naloxone spray market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the naloxone spray industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.